Open AccessPrevalence of sarcopenia using different methods in patients with non-alcoholic fatty liver disease
Author(s) -
Neogélia Almeida,
Raquel Rocha,
Claudineia Almeida de Souza,
Ana Carolina Sirelli da Cruz,
Bruna dos Reis Ribeiro,
Luiza Valois Vieira,
Carla Daltro,
Rafael Silva,
Manoel Sarno,
Helma Pinchemel Cotrim
Publication year - 2022
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v14.i8.1643
Subject(s) - sarcopenia , medicine , steatosis , fatty liver , gastroenterology , body mass index , overweight , fibrosis , disease
Sarcopenia is a clinical condition associated with several liver diseases and it includes non-alcoholic fatty liver disease (NAFLD) in its broad spectrum as steatosis, steatohepatitis and fibrosis. However, the criteria to define sarcopenia are diverse, and even those established in consensus have been discussed regarding their performance in making an accurate diagnosis.